Experiences with
Dacarbazine3 public posts
Chemotherapy Dacarbozine vs Nivo: 5 year outcomes
This study compares using a chemotherapy drug dacarbazine vs nivolumab (Optivo) with Wild Type Stage 3-4 melanoma adding to body of evidence that PD-1's have superior outcomes for overall survival to 5 years in melanoma patients, regardless of BRAF type. But we still have a long way to go.
Want to take advantage of all our features? Just log in!
or